Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1120EUR
−4.51 MEUR
860.46 KEUR
48.92 M
About BIOSERVO TECHNOLAB
Sector
Industry
Headquarters
Kista
Website
Employees (FY)
29
Founded
2003
ISIN
SE0009779085
FIGI
BBG00H2QL927
Bioservo Technologies AB engages in the development, manufacture, and marketing of wearable non-invasive devices. Its products include gloves that are well-suited to medical rehabilitation, and to preventive use in a variety of industrial applications under the Bioservo SEM technology brand. The company was founded by Hans von Holst, Jan Wikander, and Johan Ingvast in 2006 and is headquartered in Kista, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange BIOSERVO TECHNOLAB stocks are traded under the ticker 10B.
BIOSERVO TECHNOLAB is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track BIOSERVO TECHNOLAB financials in yearly and quarterly reports right on TradingView.
10B net income for the last quarter is −842.04 K EUR, while the quarter before that showed −1.01 M EUR of net income which accounts for 16.50% change. Track more BIOSERVO TECHNOLAB financial stats to get the full picture.
No, 10B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 10B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOSERVO TECHNOLAB stock right from TradingView charts — choose your broker and connect to your account.
As of May 9, 2024, the company has 29.00 employees. See our rating of the largest employees — is BIOSERVO TECHNOLAB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOSERVO TECHNOLAB EBITDA is −3.98 M EUR, and current EBITDA margin is −563.49%. See more stats in BIOSERVO TECHNOLAB financial statements.